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Introduction
In most mammals, mature erythrocytes lack nuclei and 
organelles.1,2 Erythrocytes have nuclei during the early phase of 
erythropoiesis, but they expulse the nucleus and remove all intra-
cellular organelles, including mitochondria, Golgi apparatus, and 
endoplasmic reticula (ERs), during terminal differentiation.3-7 
As a result, mature erythrocytes contain more hemoglobin to 
transport oxygen and produce energy purely through the glyco-
lytic pathway.5,8 The mechanisms by which erythrocytes remove 
organelles from developing erythroid cells are still being investi-
gated. Because mitochondria are the most abundant organelles 
in immature erythrocytes, removal of mitochondria is a major 
process for the completion of erythropoiesis.9-11
Autophagy is a regulated catalytic pathway that includes the 
engulfment of cytoplasmic components, including long-lived 
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AMP-activated protein kinase α1 knockout (prkaa1−/−) mice manifest splenomegaly and anemia. The underlying 
molecular mechanisms, however, remain to be established. in this study, we tested the hypothesis that defective autoph-
agy-dependent mitochondrial clearance in prkaa1−/− mice exacerbates oxidative stress, thereby enhancing erythrocyte 
destruction. The levels of ULK1 phosphorylation, autophagical flux, mitochondrial contents, and reactive oxygen species 
(ROS) were examined in human erythroleukemia cell line, K562 cells, as well as prkaa1−/− mouse embryonic fibroblasts and 
erythrocytes. Deletion of Prkaa1 resulted in the inhibition of ULK1 phosphorylation at Ser555, prevented the formation 
of ULK1 and BecN1- Ptdins3K complexes, and reduced autophagy capacity. The suppression of autophagy was associ-
ated with enhanced damaged mitochondrial accumulation and ROS production. compared with wild-type (WT) mice, 
prkaa1−/− mice exhibited a shortened erythrocyte life span, hemolytic destruction of erythrocytes, splenomegaly, and 
anemia, all of which were alleviated by the administration of either rapamycin to activate autophagy or Mito-tempol, a 
mitochondria-targeted antioxidant, to scavenge mitochondrial ROS. Furthermore, transplantation of WT bone marrow 
into prkaa1−/− mice restored mitochondrial removal, reduced intracellular ROS levels, and normalized hematologic param-
eters and spleen size. conversely, transplantation of prkaa1 −/− bone marrow into WT mice recapitulated the prkaa1−/− 
mouse phenotypes. We conclude that PRKAA1-dependent autophagy-mediated clearance of damaged mitochondria is 
required for erythrocyte maturation and homeostasis.
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erythrocytes.41-45 The underlying mechanism, however, remains 
to be established.
In this study, we hypothesize that PRKAA1 modulates eryth-
rocyte homeostasis by regulating the selective degradation of 
mitochondria by autophagy (mitophagy). Here, we report that 
PRKAA1 inactivation decreases ULK1 phosphorylation, inhib-
its autophagy-dependent mitochondrial clearance, and increases 
mitochondrial accumulation, resulting in the hemolytic destruc-
tion of erythrocytes via excessive mitochondrial ROS.
Results
Deletion of Prkaa1 reduces ULK1 phosphorylation in mouse 
TFRC+/CD71+ and GYPA+/Ter119+ erythroid precursors
To investigate whether AMPK has a functional role in the 
regulation of erythrocyte maturation, we first examined the pro-
tein levels of PRKAA isoforms in TFRC+ and GYPA+ erthyroid 
precursors isolated from the bone marrows of WT, prkaa1−/−, 
and prkaa2−/−. The expression of PRKAA1 in WT TFRC+ and 
GYPA+ erthyroid precursors was not different from that in 
prkaa2−/− cells (Fig. 1A). Deletion of the prkaa1 gene completely 
proteins and organelles, and delivery of the 
cargos to lysosomes for hydrolytic degrada-
tion.12,13 Initially, autophagy has been consid-
ered a nonselective process,14-17 but recent 
evidence suggests that autophagy may spe-
cifically target intracellular pathogens and 
organelles such as mitochondria and peroxi-
somes.17,18 The specific autophagic elimination 
of mitochondria (mitophagy) is a well-char-
acterized cargo-specific process19-21 that has 
been implicated in mitochondrial clearance 
during reticulocyte maturation,22-24 however 
the mechanisms regulating the removal of 
mitochondria from developing erythrocytes 
are incompletely understood.
The AMP-activated protein kinase 
(AMPK), a serine/threonine kinase conserved from yeast to 
humans, senses the cellular energy status and controls energy 
homeostasis by regulating glucose and lipid metabolism.25,26 
Mammalian AMPK consists of α, β, and γ subunits, and the 
α-subunit contains a catalytic kinase domain and exists as either 
the α1 or α2 isoform. AMPK is activated in response to vari-
ous cellular stresses, including hypoxia, nutrient deprivation, 
and oxidative stress.7,27 Once activated, AMPK phosphorylates 
and regulates several downstream molecules that reduce energy 
demand and increase energy supply. In addition, AMPK also 
regulates many other cellular processes, including mitochon-
drial biogenesis,28,29 apoptosis, and autophagy.30-33 As autophagy 
and AMPK are both stimulated by nutrient deprivation,34,35 it 
is reasonable to connect AMPK activation to increased auto-
phagic activity. Indeed, activated AMPK phosphorylates and 
activates ULK1 (unc-51 like autophagy activating kinase 1), 
a mammalian ortholog of yeast Atg1 (autophagy-related 1), 
which initiates the autophagic process.36-39 In the heart, activa-
tion of AMPK by metformin induces autophagy and protects 
against cardiac apoptosis.32,40,41 In addition, several recent stud-
ies demonstrated that prkaa1−/− and prkag1−/− mice manifest ane-
mia with splenomegaly and increased hemolytic destruction of 
Figure  1. Deletion of prkaa1 inhibits ULK1 phos-
phorylation. (A) cell lysates prepared from WT, 
prkaa1−/−, and prkaa2−/− TFRc+ and GYPA+ erythroid 
precursors were subjected to western blot analy-
ses to detect the expression of PRKAA1, PRKAA2, 
and total PRKAA. (B) expression of total and phos-
phorylated ULK1 (Ser555) in mouse TFRc+ and 
GYPA+ erythroid precursors was analyzed by west-
ern blotting. (C) The expression of ULK1 was quan-
tified by densitometry and normalized to AcTB 
(n = 4). (D and E) ATG protein levels in mouse TFRc+ 
and GYPA+ erythroid precursors were detected by 
western blotting (D) and quantified by densitom-
etry (E). (F) K562 cells were treated with AicAR 
(2 mM) or compound c (10 μM) for 4 h, and the 
cell lysates were subjected to western blotting to 
determine the phosphorylation of PRKAA (Thr172) 
and ULK1 (Ser555). The blot shown is representa-
tive of 3 independent replicates. con, control; 
comp c, compound c.
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inhibited PRKAA1 protein expression in prkaa1−/− TFRC+ and 
GYPA+ erthyroid precursors (Fig. 1A). Western blot analy-
sis using a PRKAA2 antibody that recognized PRKAA2 in 
mouse embryonic fibroblasts (MEFs) did not detect PRKAA2 
isoform in prkaa2−/− TFRC+ and GYPA+ erythroid precursors 
(Fig. S1). Unexpectedly, the PRKAA2 isoform was not detected 
in WT and prkaa1−/− TFRC+ and GYPA+ erthyroid precursors 
either (Fig. 1A). To rule out the possibility that the PRKAA2 
antibody did not work well in erythroid precursors, we used an 
antibody that recognizes both PRKAA1 and PRKAA2 isoforms 
to approach the amount of PRKAA2 isoform. The western blot 
indicated that the expression of total PRKAA was significantly 
Figure  2. Reduced ULK1 phosphorylation inhibits the formation of ULK1 and 
BecN1-Ptdins3K complexes. (A and B) cell lysates prepared from WT and prkaa1−/− 
MeFs were immunoprecipitated (iP) with anti-ULK1 antibody, and the immunopre-
cipitates were probed by western blotting (iB) with the indicated antibodies. (C) 
The expression of RB1cc1, ATG101, and ATG13 in WT and prkaa1−/− TFRc+ and GYPA+ 
reticulocytes was analyzed by western blotting. (D) The expression of AMBRA1 and 
Ptdins3K in WT and prkaa1−/− reticulocytes was analyzed by western blotting. (E) 
The cell lysates from WT and prkaa1−/− MeFs were immunoprecipitated with anti-
Ptdins3K antibody and the immunoprecipitates were probed by western blotting 
with indicated antibodies. (F) The interaction among AMBRA1, Ptdins3K, and BecN1 
was assessed by immunoprecipitation and western blotting. The blot shown is rep-
resentative of 3 independent repeats. *P < 0.05 vs. WT.
inhibited in prkaa1−/− TFRC+ and GYPA+ erythroid 
precursors but its expression in prkaa2−/− TFRC+ 
and GYPA+ erythroid precursors remained similar to 
that in WT TFRC+ and GYPA+ erythroid precursors 
(Fig. 1A). The residual band detected in prkaa1−/− 
TFRC+ and GYPA+ erthyroid precursors suggested that 
the expression of PRKAA2 was very low in these cells 
(Fig. 1A). Thus, PRKAA1 is the predominant isoform 
of PRKAA in TFRC+ and GYPA+ erythroid precursors.
Recent reports have indicated that ULK1 is required 
for autophagy.38 To test whether AMPK regulates the 
autophagic pathway during erythrocyte maturation, 
the expression of ATG proteins and phosphorylation of 
ULK1 (Ser555) were determined in WT and prkaa−/− 
TFRC+ and GYPA+ erythroid precursors. Compared 
with the cells from WT or prkaa2−/− mice, prkaa1−/− 
TFRC+ and GYPA+ erythroid precursors exhibited sig-
nificantly reduced ULK1 phosphorylation (Fig. 1B and 
C). However, there was no obvious change in ATG5, 
ATG6, and ATG7 protein levels in TFRC+ and GYPA+ 
erythroid precursors from prkaa1−/− and prkaa2−/− mice 
as compared with the cells form WT mice (Fig. 1D 
and E), suggesting that the deletion of Prka may sup-
press autophagy by reducing ULK1 activity.
To validate the effect of AMPK on ULK1 phosphor-
ylation, K562 cells (a human erythroleukemia cell line) 
were treated with 5-aminoimidazole-4-carboxamide 
ribonucleoside (AICAR), a potent AMPK activator, or 
compound C (a potent AMPK inhibitor). Total and 
phosphorylated ULK1 levels were measured by western 
blotting. AICAR increased AMPK phosphorylation at 
Thr172 and ULK1 phosphorylation at Ser555 (Fig. 1F). 
By contrast, Compound C reduced AMPK phosphory-
lation at Thr172 and lowered ULK1 phosphorylation 
at Ser555 (Fig. 1F). Overall, these data are suggestive 
of AMPK-dependent ULK1 phosphorylation in K562 
cells.
Reduced ULK1 phosphorylation at Ser555 inhib-
its ULK1 complex formation and disrupts the asso-
ciation between AMBRA1 and PtdIns3K
ULK1 complex formation and activation are 
required for autophagy initiation, we therefore tested 
whether the suppression of ULK1 phosphorylation at 
Ser555 in PRKAA1–deficient cells impaired ULK1 
complex formation and activation. Although the inhibition of 
ULK1 phosphorylation had no effect on protein levels of com-
plex components, ATG13, ATG101, and RB1CC1, in both retic-
ulocytes (Fig. 2C) and MEFs (Fig. S2A), the low level of ULK1 
phosphorylation prevented the association between ULK1 and 
RB1CC1 in reticulocytes (Fig. 2A and B), thereby disrupting the 
ULK1 complex.
We further examined the effect of low ULK1 phosphoryla-
tion on the formation of BECN1-PtdIns3K complex, which 
is essential in vesicle nucleation during autophagy. Western 
blot analysis in WT and prkaa1−/− reticulocytes (Fig. 2D) and 
MEFs (Fig. S2B) did not show any difference in protein levels of 
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AMBRA1 and BECN1. However, immu-
noprecipitation of PtdIns3K followed by 
probing for AMBRA1 and BECN1 (or the 
reverse experiment) indicated that dele-
tion of PRKAA1 disrupted the association 
between PtdIns3K and AMBRA1 (Fig. 2E 
and F). Thus, autophagy signaling was 
defective in prkaa1−/− reticulocytes.
Lack of PRKAA1 leads to suppression 
of autophagy
During autophagy, the cytosolic form 
of MAP1LC3 (microtubule-associated 
protein 1 light chain 3), LC3-I, a mamma-
lian ortholog of yeast Atg8, is conjugated 
to phosphatidylethanolamine to form the 
LC3–phosphatidylethanolamine conjugate 
(LC3-II), which is recruited to phago-
phore membranes and serves as a reliable 
marker of autophagosome formation.46,47 
Because deletion of PRKAA1 results in 
defects in autophagy signaling, we deter-
mined whether the deletion of PRKAA1 
suppresses autophagy by analyzing the con-
version of LC3-I to LC3-II in reticulocytes 
in the presence or absence of CQ. In the 
absence of CQ, the deletion of PRKAA1 
reduced LC3-II protein levels (Fig. 3A). 
Conversely, the addition of CQ enhanced 
LC3-II levels in WT reticulocytes but 
failed to do it in prkaa1−/− reticulocytes, 
indicating that autophagy was inhibited 
in prkaa1−/− reticulocytes (Fig. 3A). The 
role of PRKAA1 in LC3 processing was 
also analyzed in prkaa1−/− MEFs. Similar 
to the finding in the reticulocytes, dele-
tion of Prkaa1 impaired the conversion of 
LC3-I to LC3-II (Fig. 3B). Administration 
of CQ significantly enhanced LC3-II lev-
els in WT MEFs but not in prkaa1−/− MEFs 
(Fig. 3B), confirming that PRKAA1 regu-
lated autophagy.
We further monitored the effect of 
PRKAA1 on autophagic flux by conduct-
ing GFP-LC3 cleavage assay in WT and 
prkaa1−/− MEFs. Free GFP fragments were 
lower in prkaa1−/− MEFs than in WT 
MEFs. Treatment with CQ dramatically 
increased free GFP fragments in WT MEFs 
but not in prkaa1−/− MEFs (Fig. 3C). To confirm the effect of 
PRKAA1 on autophagosome formation, we performed immu-
nofluorescence analysis in the MEFs transfected with GFP-LC3 
and treated with or without CQ because the number of punc-
tate LC3 and GFP-LC3 structures per cell is usually an accurate 
measure of autophagosomes.46 Although there was no significant 
difference in GFP-LC3 puncta between WT and prkaa1−/− MEFs 
in the absence of CQ, the addition of CQ significantly increased 
autophagosome formation in WT MEFs, whereas this effect was 
absent in prkaa1−/− MEFs (Fig. 3D and E). These results indicate 
that PRKAA1 deficiency reduces autophagosome formation.
Defects in autophagy delay mitochondrial clearance in 
prkaa1−/− erythrocytes
Erythrocyte maturation involves the coordinated removal 
of organelles.23,48 Because autophagy has been implicated in the 
removal of mitochondria during erythrocyte maturation,22-24 
Figure 3. inhibition of PRKAA1 suppresses autophagic flux in erythrocytes. (A) WT and prkaa1−/− 
TFRc+ and GYPA+ reticulocytes from peripheral blood were treated with or without 5 μM cQ for 
6 h, and the ratio of Lc3-ii/Lc3-i were determined by western blotting. *P < 0.05 vs. WT; n = 4. 
(B) WT and prkaa1−/− MeFs were treated with or without cQ (5 μM) for 6 h and Lc3-ii/Lc3-i was
analyzed by western blotting. (C) WT and prkaa1−/− MeFs were treated with or without cQ (5 μM) 
for 6 h after infected with an adenovirus encoding GFP-Lc3 for 24 h. GFP-Lc3 and cleaved GFP 
were detected by using western blotting with an anti-GFP antibody. (D and E) WT and prkaa1−/− 
MeFs were infected with an adenovirus encoding GFP-Lc3, for 24 h and then treated with or with-
out cQ (5 μM) for 16 h. (D) Representative microphotograph of GFP-Lc3 signal. (E) Autophagic 
vacuoles (AVs) were quantified by counting the GFP-Lc3 puncta in the cells (n = 3, *P < 0.05 vs. 
WT, †P < 0.05 vs. WT/cQ).
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we examined whether defects in autophagy lead to mitochon-
drial retention during erythrocyte maturation by using flow 
cytometry after staining the cells with MitoTracker Deep Red 
and phycoerythrin-conjugated anti-GYPA (PE-anti-GYPA). As 
shown in Figure 4A and Figure S3, the mitochondrial content 
in prkaa1−/− reticulocytes was significantly higher than that in 
WT reticulocytes throughout the study period. In addition, the 
expression of mitochondrial protein, TOMM20, was also higher 
in prkaa1−/− than in WT reticulocytes 
(Fig. 4B), suggesting that mitochondrial 
clearance was delayed in prkaa1−/− reticu-
locytes. To further establish the role of 
autophagy in mitochondrial retention, 
mitochondrial content was measured in 
WT reticulocytes treated with autophagy 
inhibitors, 5 mM 3-methyladenine 
(3-MA), 100 nM wortmannin (WM), or 
5 μM CQ. The inhibition of autophagy 
led to increased mitochondrial content in 
WT reticulocytes to a similar extent as 
observed after Prkaa1 deletion (Fig. 4C).
We next assayed whether PRKAA1 
plays a role in the regulation of mito-
chondrial clearance during erythroid 
maturation by promoting ULK1 phos-
phorylation. Transfection of ULK1- or 
PRKAA1-specific siRNA into human 
K562 cells significantly reduced ULK1 
phosphorylation (Fig. 4D and E). After 
ULK1 or PRKAA1 siRNA transfection, 
K562 cells were induced to undergo 
erythrocyte maturation by 50 nM ara-
binofuranosylcytosine (Ara-C) for 6 
ds, and mitochondrial removal during 
erythrocyte differentiation was analyzed 
by MitoTracker Deep Red staining and 
flow cytometry. As shown in Figure 4E 
and F, depletion of either PRKAA1 or 
ULK1 increased mitochondrial content 
in the cells, indicating that PRKAA1 
and ULK1 are central to the regulation 
of mitochondrial removal, a key event in 
erythrocyte maturation.
Damaged mitochondria accumu-
late in prkaa1−/− reticulocytes and 
erythrocytes
We further tested whether mitochon-
drial removal is altered in prkaa1−/− retic-
ulocytes and erythrocytes in vivo using 
MitoTracker Deep Red as a mitochon-
drial probe. prkaa1−/− but not prkaa2−/− 
reticulocytes had a significantly higher 
mitochondrial content than did WT 
reticulocytes (Fig. 5A–C), as evidenced 
by a higher percentage of reticulo-
cytes that were maximally stained by 
MitoTracker Deep Red (Fig. 5B) and MFI (Fig. 5C). Double 
staining with the RNA-specific dye thiazole orange (TO) and 
MitoTracker Deep Red confirmed that prkaa1−/− reticulocytes 
had more mitochondria than WT reticulocytes (Fig. 5D and F). 
Additionally, co-staining of erythrocytes with anti-TFRC (to dis-
tinguish mature and immature erythrocytes) and MitoTracker 
Deep Red demonstrated that prkaa1−/− mice had a significantly 
higher percentage of TFRC− mature erythrocytes containing 
Figure  4. Defective autophagy delays mitochondrial clearance in prkaa1−/− reticulocytes. 
(A) Reticulocytes enriched at d 5 after phlebotomy treatment were cultured for in vitro maturation 
for 0, 1, 2, 3, and 4 d. The mitochondrial content in reticulocytes was determined by flow cytom-
etry after staining the cells with MitoTracker Deep Red and phycoerythrin-conjugated anti-GYPA 
(Pe-anti-GYPA). *P < 0.05 vs. WT. (B) The expression of mitochondrial protein, TOMM20, was detected 
at the indicated time points by western blotting. (C) WT reticulocytes harvested at d 5 after phle-
botomy were cultured for in vitro maturation for 4 ds in the presence of 5 mM 3-MA, 100 nM WM, or 
5 μM cQ. Mitochondrial content was assessed by staining the cells with MitoTracker Deep Red and 
phycoerythrin–anti-GYPA and flow cytometry. *P < 0.05 vs. WT vehicle (Veh). (D) K562 cells were 
transfected with control siRNA (c-siRNA) or PRKAA1 siRNA (PRKAA1-si) for 48 h. cell lysates were sub-
jected to western blotting by probing with antibodies to P-AMPK and P-ULK1. (E and F) K562 cells 
were first transfected with c-siRNA or PRKAA1-si, ULK1-si for 24 h and then treated with 50 nM Ara-c 
for 6 ds. After the treatment, the expression of ULK1 and P-ULK1 was analyzed by western blotting 
(E). The cells were stained with MitoTracker Deep Red and analyzed by flow cytometry to determine 
mitochondrial content (F). *P < 0.05 vs. c-siRNA.
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mitochondria compared with WT 
mice (Fig. 5G and H). These data 
indicated that the ability of prkaa1−/− 
reticulocytes to remove mitochon-
dria was insufficient. Although 
electron microscope analysis did 
not find an increase in cell volume 
in prkaa1−/− erythrocytes, it revealed 
prkaa1−/− mouse peripheral blood 
had more irregularly shaped eryth-
rocytes (Fig. S4), and a significant 
proportion of the peripheral blood 
cells contained mitochondrial rem-
nants, which was rarely observed in 
WT cells (Fig. 6A and B). A simi-
lar phenomenon was also found in 
the erythroid cells collected from 
bone marrow and spleen (Fig. S5). 
The micrographs also indicated that 
the prkaa1−/− erythrocytes contained 
more mitochondrial remnants than 
did WT erythrocytes (Fig. 6C and 
D). When mitochondrial remnants 
were found in WT erythrocytes, 
they were often present within auto-
phagosomes. Notably, many intact 
mitochondria were observed in 
prkaa1−/− erythrocytes (Fig. 6A and 
C). Western blot analysis of mito-
chondrial proteins, TOMM20 and 
COX4I1, in reticulocytes indicated 
that the protein levels of TOMM20 
and COX4I1 were higher in 
prkaa1−/− reticulocytes than in 
WT cells (Fig. 6E and F). Using 
TMRM, a potentiometric dye that 
accumulates only in intact polarized 
mitochondria, prkaa1−/− reticulo-
cytes were found to contain more 
mitochondria with lower membrane 
potential compared with WT retic-
ulocytes (Fig. 6G). Taken together, 
deletion of Prkaa1 results in dam-
aged mitochondrial accumulation 
in reticulocytes and erythrocytes. 
We also found that erythrocytes from prkaa1−/− mice contained 
more ERs than WT erythrocytes (Fig. S6). However, the nuclear 
numbers in erythrocytes were not different between WT and 
prkaa1−/− mice (Fig. S7), indicating that Prkaa1 deletion did not 
affect the ability of erythrocytes to extrude the nucleus during 
erythrocyte maturation.
Delayed mitochondrial clearance increases oxidative stress 
and erythrocyte damage
We previously have reported that prkaa1−/− mice manifest 
anemia with increased reticulocyte numbers, a shortened eryth-
rocyte life span, and increased ROS production.43,44 In addition 
to producing energy, mitochondria are a major source of ROS. 
Accumulation of depolarized mitochondria has been associated 
with oxidative damage, we therefore tested whether retention of 
damaged mitochondria in erythrocytes results in oxidative stress 
in the cells. We used 2 methods to measure ROS production. 
First, erythrocytes were stained with H2DCFDA and analyzed 
by flow cytometry. In basal conditions, the number of eryth-
rocytes generating ROS was significantly increased in prkaa1−/− 
mice compared with the findings in WT mice (Fig. 7A–C). We 
next measured mitochondrial superoxide anion production by 
MitoSOX staining and found that superoxide production was 
Figure 5. Analysis of mitochondrial content in erythrocytes by flow cytometry. (A–C) Mitochondrial con-
tent in TFRc+ and GYPA+ reticulocytes was determined by staining the cells with MitoTracker Deep Red 
and flow cytometry. (A) Representative contour plots of WT, prkaa1−/−, and prkaa2−/− reticulocytes stained 
with MitoTracker. The percentage of the cells maximally stained by MitoTracker Deep Red and the mean 
fluorescent intensity (MFi) were determined by gating on TFRc+ and GYPA+ reticulocytes. (B) Percentage 
of TFRc+ and GYPA+ reticulocytes that were maximally stained by MitoTracker Deep Red, *P < 0.05 vs. WT. 
(C) Mean fluorescent intensity (MFi) of MitoTracker Deep Red, *P < 0.05 vs. WT. (D) Peripheral blood erythro-
cytes were stained with MitoTracker Deep Red and TO followed by flow cytometry analysis. (E) Percentage 
of reticulocytes in WT and prkaa1−/− peripheral blood. (F) Percentage of reticulocytes containing mito-
chondria, *P < 0.05 vs. WT. (G) Representative contour plots of flow cytometry analysis of peripheral blood 
erythrocytes stained with MitoTracker Deep Red and TFRc. (H) Percentage of mature erythrocytes (TFRc−) 
containing mitochondria. *P < 0.05 vs. WT.
1528 Autophagy Volume 10 issue 9
significantly increased in the erythro-
cytes of prkaa1−/− mice (Fig. 7D and E).
Next, we examined whether or not 
enhanced oxidative stress promotes 
erythrocyte destruction. Consistent 
with our previous finding,43,44 prkaa1−/− 
erythrocytes are more resistant to 
hypotonic lysis than WT erythro-
cytes (Fig. S8), indicating a reduction 
in cell surface to volume ratio, which 
may potentiate erythrocyte destruc-
tion in an unfavorable environment. In 
line with the fact that oxidative stress 
induces cell damage, prkaa1−/− mice 
had more ANXA5+/annexin V+ eryth-
rocytes than did WT mice (Fig. 7F 
and G). Together with our previous 
finding that prkaa1−/− erythrocytes are 
Figure  6. Retention of mitochondria in 
prkaa1−/− erythrocytes. (A) Representative 
electron micrographs of WT and prkaa1−/− 
erythrocytes (Scale bars: 500 nm). Arrows: 
mitochondrial remnants. (B) erythrocytes 
containing remnants of mitochondria and 
other organelles were quantified, and the 
percentage of erythrocytes containing 
fragmented organelles was calculated. 
(C) Representative electron micrographs
of WT and prkaa1−/− erythrocytes (Scale
bars: 100 nm). in WT erythrocytes, the
arrow points to an autophagosome; in
prkaa1−/− erythrocytes, the arrows point
to mitochondria. (D) The number of mito-
chondria and membranes in each cell was 
quantified. (E and F) Mitochondrial pro-
teins (cOX4i1 and TOMM20) in WT and
prkaa1−/− TFRc+ and GYPA+ reticulocytes
were analyzed by western blotting (M)
and quantified by densitometry and nor-
malized to AcTB. n = 4, *P < 0.05 vs. WT.
(G) Percentage of TFRc+ and GYPA+ reticu-
locytes that were stained by TMRM, ***P < 
0.001 vs. WT.
Figure  7. Deletion of prkaa1 enhances 
intracellular ROS levels and cell damage. 
(A–C) erythrocyte intracellular ROS levels 
were determined by flow cytometry using 
h2DcFDA as a probe. (A) Representative 
contour plots of WT and prkaa1−/− eryth-
rocytes stained with h2DcFDA. (B) 
Percentage of erythrocytes generat-
ing ROS. (C) MFi of h2DcFDA. (D and 
E) erythrocyte intracellular superoxide
was stained with MitoSOX and detected
by flow cytometry. The superoxide lev-
els was expressed as the percentage of
erythrocytes containing MitoSOX (n = 5, 
*P < 0.05 vs. WT). (F) Representative
diagram of ANXA5-Pi staining. (G) 
Percentage of ANXA5+ erythrocytes (n = 5, 
*P < 0.05 vs. WT).
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less deformable in response to shear stress than con-
trol erythrocytes,43 our results suggest that prkaa1−/− 
erythrocytes are more susceptible to damage.
Chronic administration of the antioxidant 
Mito-tempol ameliorates anemia in prkaa1−/− mice
Because prkaa1−/− erythrocytes exhibited higher 
levels of ROS and superoxide, we tested whether 
administration of Mito-tempol, a mitochondria-
targeted antioxidant, could improve erythrocyte 
survival and ameliorate anemia. As depicted in 
Figure 8, the chronic administration of Mito-
tempol in prkaa1−/− mice decreased ROS and super-
oxide levels (Fig. 8A and B), reduced mitochondrial 
accumulation (Fig. 8C), and recovered erythrocyte 
numbers, hemoglobin levels, and percentage of 
reticulocytes compared with the findings in vehicle-
treated prkaa1−/− mice (Table 1), suggesting that 
Prkaa1 deletion induces anemia through enhancing 
mitochondria-mediated oxidative stress.
Chronic administration of rapamycin amelio-
rates anemia in prkaa1−/− mice
To understand the role of autophagy in Prka 
deletion-induced anemia, we assessed the impact of 
rapamycin, an autophagy inducer, on the Prkaa1-
knockout phenotype. Compared with control 
prkaa1−/− mice, chronic administration of rapamycin 
partially recovered erythrocyte numbers and hemo-
globin levels (Table 1). At the same time, rapamycin 
treatment attenuated oxidative stress in these mice, 
as estimated by the reduction in mitochondrial con-
tent (Fig. 8C) and the decreases in intracellular lev-
els of ROS and superoxide anions (Fig. 8A and B).
Transplantation of WT bone marrow com-
pletely restores the erythroid phenotype in 
prkaa1−/− mice
The aforementioned observations prompted us to per-
form bone marrow transplantation to examine the impact 
of PRKAA1 deficiency on erythrocyte terminal differentia-
tion and maturation in vivo. Compared with the WT mice 
that received WT bone marrow cells, the WT mice trans-
planted with prkaa1−/− bone marrow exhibited significantly 
lower erythrocyte counts and hemoglobin concentrations and 
higher reticulocyte counts (Table 2). Transplantation also 
dramatically elevated the mitochondrial content (Fig. 9A and 
B), enhanced ROS and superoxide production (Fig. 9C and 
D), and increased immature erythrocytes (TFRC+GYPA+ 
and TFRClow GYPA+) (Fig. 9F and G) in peripheral blood. 
Furthermore, erythrocytes from WT mice transplanted with 
prkaa1−/− bone marrow cells displayed a comparable magnitude 
and spectrum of osmotic resistance (Fig. S8), as we previously 
reported in prkaa1−/− erythrocytes.43,44 Hence, the hematologic 
phenotype of prkaa1−/− mice was recapitulated by bone marrow 
transplantation, indicating that PRKAA1 plays an intrinsic role 
in erythrocyte homeostasis.
To determine whether deletion of Prkaa1 alters the hemato-
poietic microenvironment for erythropoiesis and erythrocyte 
Table 1. hematological parameters of the peripheral blood from mice 
treated with Mito-tempol or rapamycin
WT prkaa1−/−
Vehicle Rapa Mito-tempol
RBc (M/µl) 8.8 ± 0.7 6.1 ± 0.6 7.4 ± 0.9* 8.1 ± 0.6*
hb (g/dl) 13.8 ± 1.0 9.1 ± 0.5 11.0 ± 1.4* 12.6 ± 0.7*
Reti (%) 4.5 ± 0.5 18.0 ± 1.5 14.5 ± 2.3 7.0 ± 2.5*
*P < 0.05 vs. prkaa1−/− /vehicle; Rapa, rapamycin; Reti, reticulocyte; hb, 
hemoglobin.
Table 2. hematological parameters of peripheral blood from BMT mice
Recipient WT prkaa1−/−
Donor WT BM prkaa1−/− BM WT BM prkaa1−/− BM
RBc (M/μl) 8.9 ± 0.6 7.4 ± 0.1* 8.9 ± 0.3 6.9 ± 0.2†
hb (g/dl) 12.8 ± 0.7 9.9 ± 0.5* 13.0 ± 0.6 8.8 ± 0.2†
Reti (%) 4.5 ± 0.2 14.2 ± 0.6* 4.5 ± 0.4 19.8 ± 0.6†
*P < 0.05 vs. WT BM/WT; †P < 0.05 vs. WT BM/ prkaa1−/−; Reti, reticulocyte;
hb, hemoglobin
Figure  8. Rapamycin and Mito-tempol attenuate oxidative stress and anemia in 
prkaa1−/− mice. (A) intracellular ROS levels in erythrocytes were determined as described 
in Materials and Methods, and the results are presented as percentages of erythrocytes 
containing h2DcFDA. (B) intracellular superoxide content was determined by staining 
erythrocytes with MitoSOX and analyzed by flow cytometry. The results were expressed 
as percentages of erythrocytes containing MitoSOX. (C) Mitochondrial content in eryth-
rocytes was assessed by MitoTracker Deep Red staining, and the results are presented 
as the percentage of MitoTracker Deep Red+ erythrocytes (n = 5, *P < 0.05 vs. prkaa1−/− 
vehicle); NS, not significant; Rapa, rapamycin; Mito-temp, Mito-tempol.
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transplantation of WT hematopoietic 
cells reduced erythropoietin (Epo) 
mRNA expression in prkaa1−/− recipi-
ent mice (Fig. 9E).
Consistent with previous reports42-44 
marked splenomegaly was observed in 
both WT and prkaa1−/− mice trans-
planted with prkaa1−/− bone marrow 
cells (Fig. 10A and B). When prkaa1−/− 
mice were transplanted with WT bone 
marrow cells, their spleen size was 
restored to a size comparable to that of 
WT mice (Fig. 10A and B). Histologic 
analysis revealed that the red pulp was 
markedly expanded (Fig. 10E) and 
iron was accumulated in the spleens 
(Fig. 10C and D) of prkaa1−/− and WT 
mice transplanted with prkaa1−/− bone 
marrow cells compared with the find-
ings in mice transplanted with WT 
bone marrow cells. Taken together, 
these results indicate that the ane-
mia observed in prkaa1−/− mice is due 
to the defective mitophagy, which 
delays mitochondrial clearance during 
erythrocyte terminal differentiation, 
induces oxidative stress, and enhances 
hemolytic destruction of erythrocytes.
Discussion
In this study, we have demon-
strated that erythroid cells pre-
dominantly express the PRKAA1 
isoform, and genetic deletion of 
Prkaa1 impairs ULK1 phosphoryla-
tion, reduces the formation of ULK1 
and BECN1-PtdIns3K complexes, and 
subsequently suppresses autophagy-
dependent mitochondrial clearance 
during erythrocyte maturation. The 
retention of damaged mitochondria 
exacerbated mitochondria-mediated 
oxidative stress that results in the 
hemolytic destruction of erythro-
cytes, a shortened erythrocyte life 
span, splenomegaly, and anemia. All of these detrimental effects 
induced by the deletion of Prkaa1 were abolished by transplan-
tation of normal hematopoietic stem cells into prkaa1−/− mice. 
Administration of either rapamycin to activate autophagy or 
Mito-tempol to eliminate ROS ameliorates the impairments 
observed in prkaa1−/− mice. Our findings suggest that protect-
ing the ability of erythrocytes to remove damaged mitochondria 
via autophagy is an important mechanism for the PRKAA1-
mediated regulation of the erythrocyte life span.
survival, we transplanted WT hematopoietic cells into prkaa1−/− 
recipient mice and observed erythrocyte maturation in these 
mice. As depicted in Table 2, the transplantation of WT hemato-
poietic cells into prkaa1−/− recipient mice completely normalized 
blood parameters including erythrocyte counts and hemoglobin 
levels (Table 2). Transplantation also rehabilitated mitochon-
drial clearance (Fig. 9A and B), inhibited ROS, and superoxide 
production (Fig. 9C and D), and normalized erythrocyte matu-
rity (Fig. 9F and G) in prkaa1−/− recipient mice. In addition, the 
Figure 9. Stem cells from WT bone marrow completely restore the hematologic phenotype of prkaa1−/− 
mice. eight-wk-old mice were used to perform BMT experiment. Twelve wk after bone marrow cell 
transplantation, peripheral blood was analyzed. (A) erythrocytes were stained with MitoTracker Deep 
Red and phycoerythrin–anti-GYPA and analyzed by flow cytometry. (B) Mitochondrial content is 
expressed as the percentage of erythrocytes containing MitoTracker Deep Red. (C) erythrocyte intracel-
lular ROS levels were determined by flow cytometry using h2DcFDA as a probe. (D) erythrocyte intra-
cellular superoxide content was evaluated using MitoSOX staining and flow cytometry as described 
in Materials and Methods. (E) Total mRNA was extracted from the kidneys, and Epo mRNA levels were 
quantified by real-time PcR. (F and G) Peripheral blood erythroid cell differentiation. Distribution of 
erythroid developmental stages was analyzed by flow cytometry using the surface marker TFRc/cD71 
(transferrin receptor) and GYPA/Ter119 (glycophorin A [MNS blood group]).
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The most important finding of this study is 
that PRKAA1 plays a major role in erythrocyte 
homeostasis through regulating autophagy-
dependent mitochondrial clearance during eryth-
rocyte terminal differentiation. prkaa1−/− mice 
exhibit anemia with splenomegaly and increased 
hemolytic destruction of erythrocytes.42-44 
However, the underlying mechanism remains 
elusive. The present study provides direct experi-
mental evidence to support the notion that the 
anemia observed in prkaa1−/− mice is the result 
of impaired autophagy-dependent mitochondrial 
clearance and accumulation of damaged mito-
chondria, which leads to oxidative stress and pro-
motes erythrocyte destruction.
1) Mitochondrial clearance by autophagy is
impaired in prkaa1−/− erythrocytes. In addition 
to regulating energy metabolism, AMPK also 
modulates autophagy under many physiologic 
and pathologic conditions. Recently, several stud-
ies demonstrated that AMPK directly phosphory-
lates ULK1 in the mammalian liver and MEFs 
during energy stress, and the loss of either AMPK 
or ULK1 leads to defects in mitophagy.38,49 These 
studies suggest that AMPK regulates ULK1 activ-
ity through a concise mechanism, ensuring that 
ULK1 is activated only under appropriate condi-
tions. In the current study, we observed a dramatic 
decrease in ULK1 phosphorylation and sup-
pression of autophagy in prkaa1−/− erythrocytes, 
which were associated with a shortened erythro-
cyte life span and anemia. Chronic administra-
tion of rapamycin stimulates autophagy, prevents 
mitochondrial accumulation in erythrocytes, and 
ameliorates anemia in prkaa1−/− mice, suggesting a 
connection between defective autophagy and the 
development of anemia in prkaa1−/− mice. In agreement with this 
hypothesis, the phenotype of prkaa1−/− mice is similar to those of 
ulk1−/−,24 atg7−/−,11,22 and bnip3l/nix−/− mice.23,50,51 Although dele-
tion of Prkaa1 does not affect the protein levels of ATG5, ATG6, 
and ATG7, the lack of PRKAA1 does reduce ULK1 phosphoryla-
tion at Ser555, which inhibits the formation of a kinase complex 
essential for the initiation of autophagy. Although prkaa1−/− mice 
had more severe anemia than did ulk1−/− mice, prkaa1−/− mice 
exhibit a mild defect in mitochondrial clearance (12% of eryth-
rocytes containing mitochondria in total blood), which is less 
severe than that caused by deficiency of ULK1 (35%).10,24 The 
discrepancy between the severity of anemia and the defect in 
mitochondrial clearance suggests that PRKAA1 deficiency has 
an additional effect on erythroid development besides impair-
ment of mitochondrial clearance.
In addition to regulating BECN1-PtdIns3K complex forma-
tion, AMPK also coordinates with MTORC1 to regulate the 
formation and activation of ULK1 complex. Under the condi-
tions that autophagy is induced, MTORC1 dissociates from 
the complex allowing AMPK to bind and phosphorylate ULK1, 
suggesting that the physical association of AMPK and ULK1 
is important in regulating the formation of ULK1 complex. In 
the in vivo experiment, inhibition of the MTORC1 signaling by 
rapamycin in prkaa1−/− mice only partially prevented the dam-
age induced by deletion of Prkaa1, suggesting that in the absence 
of AMPK, inhibition of MTORC1 could not completely restore 
autophagic capacity. Taken together, defective autophagy may be 
an important mechanism responsible for the development of ane-
mia in prkaa1−/− mice.
2) ROS levels are significantly increased in prkaa1−/− eryth-
rocytes and administration of Mito-tempol recovers eryth-
rocyte numbers, hemoglobin levels, and reticulocyte count 
in prkaa1−/− mice. ROS are primarily generated by mitochon-
dria as a byproduct of the electron transport chain. Deletion 
of Prkaa1 impairs autophagy-dependent mitochondrial clear-
ance, leading to accumulation of depolarized mitochondria and 
increased ROS production in erythrocytes. Excessive ROS not 
only induce the nonspecific posttranslational modification of 
proteins but also cause mitochondrial dysfunction/damage, as 
mitochondria are both the producers and targets of ROS.52 In 
Figure  10. Stem cells from WT bone marrow ameliorate the splenomegaly of prkaa1−/− 
mice. (A) Representative images of spleens from bone marrow-transplanted mice. 
(B) comparison of the spleen index in different transplantation groups. (C) iron content in 
spleen sections was assessed using Perls iron stain. Scale bars: 50 μm. (D) Quantification 
of Perls stained puncta. n = 5–6; *P < 0.05 vs. mice transplanted with WT bone marrow. 
(E) The spleens collected from bone marrow-transplanted mice were analyzed by hema-
toxylin and eosin staining. Scale bars: 200 μm.
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addition, depolarization of mitochondria causes mitochondria 
to produce more ROS and release apoptosis-related factors such 
as cytochrome c into the cytosol, forming a vicious circle and 
exaggerating the damage.53 Thus, the impaired ability of eryth-
rocytes to remove dysfunctional mitochondria may damage 
the cytoplasmic membrane and associated cytoskeleton, which 
decreases erythrocyte deformability, leading to the sequestra-
tion of erythrocytes in the spleen.
3) The lack of PRKAA1 did not alter the microenvironment
for erythropoiesis and erythrocyte survival. There are many fac-
tors involved in erythrocyte destruction; the defect may occur 
within the erythrocyte itself (intrinsic factor) or outside the cell 
(extrinsic factor, also called the microenvironment). In the pres-
ent study, transplantation of WT bone marrow into prkaa1−/− 
mice resulted in mitochondrial removal, reduced intracellular 
ROS levels, and normalized hematologic parameters and spleen 
size. In addition, transplantation of prkaa1−/− bone marrow into 
WT recipients could recapitulate the phenotype of prkaa1−/− 
mice. These results suggest that the anemia induced by Prkaa1 
deletion is due to impaired autophagy-dependent mitochondrial 
clearance in erythrocytes, which worsens oxidative stress and 
promotes erythrocyte destruction, rather than alteration of the 
microenvironment of erythrocytes.
The enlargement of the spleen observed in prkaa1−/− mice 
may be a compensatory response to the hemolytic destruction 
of erythrocytes. In these mice excessive oxidative stress causes 
oxidation of membrane proteins, which may change the mem-
brane structure and impair the deformability of erythrocytes.43,44 
The damaged erythrocytes are vulnerable to sequestration in the 
spleen,43,44 leading to marked increases in iron deposition in the 
spleen. In addition, prkaa1−/− mice exhibited vigorous splenic 
hematopoiesis, as evidenced by expanded red pulp, increased 
reticulocyte numbers, and elevated plasma levels of EPO.
In conclusion, we have demonstrated that PRKAA1 plays a 
critical role in the regulation of autophagy-dependent mitochon-
drial clearance during erythrocyte differentiation, and defec-
tive autophagic clearance of damaged mitochondria contributes 
to the development of anemia and splenomegaly. Our findings 
provide new insights into the pathogenesis of hematologic dis-
eases involving defective erythrocyte maturation such as anemia 
and myelodysplastic syndrome. These findings also suggest that 




All procedures were reviewed and approved by the Institutional 
Animal Care and Use Committee at the University of Oklahoma 
Health Sciences Center and at the University Paris Descartes. 
prkaa1−/− mice backcrossed to the C57BL/6 background for 
5 generations were used for these experiments.43 To determine 
the effects of autophagy on oxidative stress during the develop-
ment of anemia, prkaa1−/− mice and their littermates (wild-type, 
WT) were treated with 200 μg/kg/d/ Mito-tempol (Santa Cruz 
Biotechonoloigy, sc-221945) through Mini Osmotic Pump 
(Model 2006, DURECT Co., 0007223) for 6 wk. In separate 
groups, mice were treated with rapamycin (LC Laboratories, 
R-5000) at dose of 3.0 mg/kg/d or 10% DMSO as vehicle con-
trol through intraperitoneal injections for 10 wk.
Peripheral blood analysis and reticulocyte cultures
Peripheral blood samples were harvested in EDTA-coated 
microtubes (Aktiengesellschaft & Co., 20.1288.100) by retro-
orbital sinus bleeding and analyzed by a HEMAVET 950 
Veterinary Hematology Analyzer (Drew Scientific Inc., Oxford, 
Connecticut) using a mouse species program. Reticulocytosis in 
the mice were induced by daily retro-orbital bleeding (0.35 mL/d) 
for 4 d. An equal volume of sterile saline was injected intraperi-
toneally to replace the lost blood. On the fifth d, whole blood 
were harvested to sort TFRC+GYPA+ cells, refered to as reticu-
locytes, and cultured for 1 to 4 d in Iscove Modified Dulbecco 
Media (ATCC, 300-2005) supplemented with 30% fetal bovine 
serum (Sigma, F2442), 1% deionized bovine serum albumin 
(Sigma, 05470), 10 U/mL insulin (Sigma, I3536), and transfer-
rin (StemCell Technologies, 36150), 0.1mM monothioglycerol 
(Sigma, M6145), 100 U/mL penicillin, 100 μg/mL streptomy-
cin, 2 mM L-glutamine, and 0.5 mM adenine hemisulfate.
Bone marrow transplantation
WT and prkaa1−/− mice were used for these experiments. 
Chimera were generated by irradiating recipient mice with 2 
doses of 550 cGy and immediately reconstituting them with 5 × 
106 donor bone marrow cells isolated from the femurs and tibias 
of WT or prkaa1−/− mice. The hematologic parameters of recipi-
ent mice were analyzed 12 wk after bone marrow transplantation.
Immunoprecipitation and western blot analysis
Protein extracts were prepared by lysing cells in radioimmu-
noprecipitation assay buffer [150 mM NaCl, 1.0% Nonidet P-40 
(Sigma, I8896), 0.5% sodium deoxycholate (Sigma, 30970), 
0.1% sodium dodecyl sulfate (Sigma, L3771), 1 mM EDTA, and 
50 mM TRIS-HCl, pH 8.0] supplemented with complete EDTA-
free protease inhibitor cocktail tablets (Roche Applied Science, 
05892953001) and phosphatase inhibitor cocktails (Sigma-
Aldrich, P0044-5ML). Cleared lysates were separated on 10% 
Tris-glycine or 4–12% Bis-Tris gels (Invitrogen, EC6028BOX) 
followed by transfer onto polyvinylidene difluoride or nitrocel-
lulose membranes. After blocking in 5% skim milk, blots were 
probed using the following primary antibodies (1:1000 dilution): 
anti-mouse ATG5, ATG7, BECN1, PRKAA1, PRKAA2, phos-
pho-PRKAA (Thr172), and phospho-ULK1 (Ser555), RB1CC1/
FIP200, AMBRA1, PIK3C3 (phosphatidylinositol 3-kinase, 
catalytic subunit type 3; the catalytic subunit of PtdIns3K), 
ATG101, ATG13, and LC3B, all of which were purchased from 
Cell Signaling Technology (catalog numbers were 8540S, 2631S, 
3495S, 2795S, 2757S, 2535, 5869, 12346,12250, 4263, 8764, 
6940, and 3868 respectively); and anti-mouse ULK1, and anti-
GFP (Sigma, A7481, and G1544). For immunoprecipitation 
assay, 500 μg of protein cleared lysates were immunoprecipitated 
with specific antibodies (1:200 dilution) overnight at 4 °C, the 
immunoprecipitates were subjected to western blot. Control, 
PRKAA1, and ULK1 siRNA were purchased from Santa Cruz 
Biotechnology (SC-37007, SC-29673, SC-44182).
www.landesbioscience.com Autophagy 1533
Flow cytometry
For erythroid developmental stages, erythroid cells from 
the peripheral blood, bone marrow, or spleens of WT and 
prkaa1−/− mice were stained with FITC–anti-TFRC and phy-
coerythrin–anti-GYPA (BD Biosciences, 553266, 553673). 
Phosphatidylserine display was measured by staining with 
FITC–ANXA5/Annexin V (BD Biosciences, 556419). To stain 
mitochondria, WT, prkaa1−/−, and prkaa2−/− erythrocytes were 
labeled with 100 nM MitoTracker Deep Red (Molecular Probes, 
M22426) at 37 °C for 30 min. To analyze mitochondrial depo-
larization, reticulocytes were stained with 100 nM tetramethyl-
rhodamine methylester (TMRM; Invitrogen, T668) at 37 °C 
for 15 min. Measurement of intracellular ROS levels in erythro-
cytes was performed essentially according to the manufacturer’s 
instruction. Briefly, erythrocytes were washed and resuspended 
in staining buffer (BD Bioscience, 554657) and loaded with 
5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diace-
tate, acetyl ester (H2DCFDA, Molecular Probes, C6827) in the 
dark for 30 min at 37 °C in a 5% CO
2
 atmosphere. Intracellular 
fluorescent products were measured immediately by flow cytom-
etry. To detect intracellular superoxide, erythrocytes were incu-
bated with 5 μM MitoSOX Red (Molecular Probes, M36008) 
at 37 °C in a 5% CO
2
 atmosphere and directly analyzed by flow 
cytometry without fixing.
Visualization of autophagic vacuoles
MEFs from WT and prkaa1−/− mice were plated at 5 × 104 
cells per well and allowed to adhere to the plate overnight. Cells 
were infected with adenovirus encoding GFP-LC3B. After 24 h 
of infection, the cells were incubated with 5 μM of chloroquine 
(CQ) for 16 h. Fluorescence images were obtained using a con-
focal microscope (Leica SP2 MP Confocal Heidelberg GmbH, 
Germany). Autophagy was measured by quantifying the average 
number of autophagic vacuoles per cell for each sample. A mini-
mum of 100 cells per sample was counted.
Assays of autophagic flux
MEFs (5 × 104) and TFRC+ GYPA+ reticulocytes from periph-
eral blood (1 × 106) were seeded in 6-well plates and grown over-
night. The cells were then treated with 5 μM of CQ for 6 h. Cell 
lysates were prepared and subjected to western blot to determine 
the ratio of LC3-II/LC3-I. To detect the dynamic turnover of 
GFP-LC3B in lysosome, GFP-LC3 cleavage assay was performed. 
Briefly, WT and prkaa1−/− MEFs were first infected with adenovi-
rus GFP-LC3 for 24 h, then the cells were treated with or without 
CQ (5 μM). Total lysates were prepared and subjected to west-
ern blot analysis. The appearance of free GFP on western blot 
can be used to monitor degradation of the inner autophagosome 
membrane. The reduced amount of free GFP fragments indicates 
the reduction in autophagic flux.
Electron microscopy
Samples were fixed by addition of 2.5% gluteraldehyde in 
0.1 mol/L phosphate buffer, pH 7.4, and left for 24 h at 4 °C. 
Samples were postfixed with 1% osmium tetroxide, dehydrated 
with 100% ethanol, and embedded in epoxy resin (Sigma, 45359-
1EA-F). Finally, ultrathin slices (70- to 100-nm thick) were cut 
from the resin blocks with a Reichert Ultracut E ultramicrotome 
(Leica Microsystems Inc. Buffalo Grove, USA), stained with 
lead citrate and uranyl acetate. Sections were examined with a 
JEOL 1010 electron microscope (JEOL USA, Inc. Peabody, MA) 
fitted with a Hamamatsu digital camera system (Hamamatsu 
Photonics, Hamamatsu City, Japan).
Perls Prussian Blue Staining
Spleen sections were deparaffinized and rehydrated. Slides 
were incubated in Perls Staining Solution (comprising equal parts 
of 2% potassium ferrocyanide and 2% hydrochloric acid), coun-
terstained with filtered neutral red (Sigma, N4638), dehydrated, 
cleared, and mounted. Images were taken using a Retiga 1300 
Color-Cooled Camera (Qimaging, Burnaby BC, Canada) and Q 
capture software and Perls stained puncta were quantified using 
a Bioquant analysis system (Nashville, TN).
Statistics
The data were presented as means ± standard errors of the 
mean. Two-group comparisons were performed using the Student 
t test. Multiple group comparisons were performed using one-way 
analysis of variance and the Fisher least significant difference. P 
values of less than 0.05 were considered statistically significant.
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